Chronic subdural hematoma outcome prediction using logistic regression and an artificial neural network.
Artificial neural networks (ANN) have not been used in chronic subdural hematoma (CSDH) outcome prediction following surgery. We used two methods, namely logistic regression and ANN, to predict using eight variables CSDH outcome as assessed by the Glasgow outcome score (GOS) at discharge. We had 300 patients (213 men and 87 women) and potential predictors were age, sex, midline shift, intracranial air, hematoma density, hematoma thickness, brain atrophy, and Glasgow coma score (GCS). The dataset was randomly divided to three subsets: (1) training set (150 cases), (2) validation set (75 cases), and (3) test set (75 cases). The training and validation sets were combined for regression analysis. Patients aged 56.5 +/- 18.1 years and 228 (76.0%) of them had a favorable outcome. The prevalence of brain atrophy, intracranial air, midline shift, low GCS, thick hematoma, and hyperdense hematoma was 142 (47.3%), 156 (52.0%), 177 (59.0%), 82 (27.3%), 135 (45.0%), and 52 (17.3%), respectively. The regression model did not show an acceptable performance on the test set (area under the curve (AUC) = 0.594; 95% CI, 0.435-0.754; p = 0.250). It had a sensitivity of 69% and a specificity of 46%, and correctly classified 50.7% of cases. A four-layer 8-3-4-1 feedforward backpropagation ANN was then developed and trained. The ANN showed a remarkably superior performance compared to the regression model (AUC = 0.767; 95% CI, 0.652-0.882; p = 0.001). It had a sensitivity of 88% and a specificity of 68%, and correctly classified 218 (72.7%) cases. Considering that GOS strongly correlates with the risk of recurrence, the ANN model can also be used to predict the recurrence of CSDH.
Abouzari
Mehdi
M
Amir-Alam Hospital, Tehran University of Medical Sciences, No.48, Alaei Alley, Ard-e-Iran Street, Shahr-e-Rey, Tehran, Iran. abouzari.m@gmail.com
Rashidi
Armin
A
Zandi-Toghani
Mehdi
M
Behzadi
Mehrdad
M
Asadollahi
Marjan
M
D000328:Adult; D000368:Aged; D019540:Area Under Curve; D005260:Female; D005500:Follow-Up Studies; D015600:Glasgow Coma Scale; D023261:Glasgow Outcome Scale; D020200:Hematoma, Subdural, Chronic / Q000628:therapy*; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016571:Neural Networks, Computer; D011237:Predictive Value of Tests; D012372:ROC Curve; D012008:Recurrence; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome